Introduction to hematopoietic stem and progenitor cells
The study of stem cells within the hematopoietic system began nearly 40 years ago, with the demonstration by Till and McCulloch that a single precursor cell exists in the bone marrow (BM) of adult animals that is capable of both extensive self-renewal and multi-lineage differentiatiation. [1] [2] [3] This finding gave rise to the hypothesis that, during hematopoiesis, a small population of multipotent, self-renewing, clonogenic stem cells divides to generate progeny cells, each progressively more restricted in developmental potential, until ultimately mature effector cells are formed. Careful regulation of cell fate decisions in the stem cell pool profoundly influences the production of mature blood cells, and is required both to maintain homeostasis and to enable rapid and robust responses to physiologic stresses, including blood loss, infection and injury.
Hematopoietic stem cells (HSC) are rare cells within the BM or fetal liver which can both self-renew and differentiate to form all of the major blood cell lineages. The HSC pool has been characterized phenotypically and is separable into distinct subpopulations based on both phenotype and function ( Figure 1) . 4, 5 Long-term reconstituting HSC (LT-HSC) have the greatest self-renewal capacity and give rise to all hematopoietic lineages throughout life. 4, 6 The immediate progeny of LT-HSC are short-term (ST-) HSC, which also generate all hematopoietic lineages, but do so for only 8-10 weeks. Further downstream are lineage-restricted oligopotent progenitor cells, including both lymphoid (common lymphoid progenitors, CLP) and myeloid (common myeloid progenitors, CMP; granulocyte-monocyte progenitors, GMP; and megakaryocyte-erythrocyte progenitors, MEP) restricted precursors. 7, 8 Multipotent, clonogenic HSC also have been identified and characterized in the fetal liver (FL).
9-11 FL HSC differ from adult HSC both phenotypically and functionally. Unlike adult LT-HSC, FL HSC express the cell surface markers Mac-1 and AA4.1, are cycling rapidly, and give a more robust and rapid reconstitution of irradiated hosts. [9] [10] [11] [12] [13] [14] [15] While adult HSC readout in CFU-S assays at day 12, FL HSC form visible colonies at day 8. 16 Finally, while the adult stem cell pool is composed mostly of short-term and multipotent progenitors, 6 most stem cells in FL are thought to be LT-HSC. 15 The oligopotent progenitors downstream of FL HSC also differ slightly from their adult counterparts ( Figure  1 ). Unlike adult CMP, FL CMP, but not GMP or MEP, give rise to B cells (but never T cells) both in vivo and in vitro. 16 Likewise, while adult CLP have no macrophage activity in vivo or in vitro, FL CLP form macrophage (but never granulocyte, erythrocyte, or megakaryocyte) colonies in methylcellulose and stromal cell cultures. 17 In addition to these differences in the lineage relationships of fetal progenitors, several blood cells that cannot be generated by adult HSC, including B-1a B cells and V␥3
+ and V␥4
+ T cells, arise during fetal hematopoiesis from fetal HSC. [18] [19] [20] The prospective isolation of HSC and progenitor cells in mice has provided key insights into the molecular and cellular regulators of hematopoiesis. Careful control of HSC developmental decisions is clearly essential for blood cell homeostasis. As discussed below, the developmental options of HSC include not only self-renewal and differentiation, but also apoptosis and migration. The synthesis of signals from diverse hematopoietic regulators ultimately determines the fate of dividing HSC.
Self-renewal versus differentiation in the control of HSC fate
Most studies of HSC cell fate determination focus on the choice between stem cell self-renewal, in which the daughter(s) of a dividing HSC retains the properties of the parent cell, and differentiation, in which the daughter cell(s) becomes restricted in its potential and diminished in its capacity for self-renewal. Both stochastic and instructive models have been proposed to describe this choice, and while both models invoke a key role for cytokines, different functions are assigned to these factors. Under the stochastic model, HSC randomly commit to either self-renew or differentiate. Cytokines present in the BM milieu do not direct this choice per se, but do allow survival and proliferation of the cells that ultimately develop into mature lineages. Under the instructive model, the particular cytokines to which HSC are exposed directly determine the outcome of each mitosis, whether self-renewing or differentiating.
While several studies support an instructive role for cytokines in the maturation of terminally differentiated cells from progenitor and precursor cells, [21] [22] [23] [24] the initial divisions of HSC are likely to involve stochastic fate choices. 25 In fact, it has been postulated that stochastic determination of HSC cell fate may be important for HSC function, in that this scheme allows for the maintenance of production of all blood cell lineages even in the face of substantial demand for one particular lineage. 26 Supporting the stochastic model for HSC differentiation, in vitro culture of Bcl-2 transgenic HSC with steel factor (SLF) alone induces these cells to proliferate, but does not preserve their primitive status. 27 This induction of HSC differentiation in the absence of any overt differentiating signals, suggests that lineage choice need not be initiated by particular cytokine signals. Similarly, lineage-restricted progenitors can develop from HSC at normal frequency, even in the absence of lineage-specific cytokines. For example, although maturation of lymphocytes from CLP requires IL-7, and IL-7 induces CLP proliferation in vitro, CLP develop at normal frequency in mice deficient in expression of the common signaling receptor (␥ c ) of the IL-7 receptor. 8 RT-PCR analysis of rigorously purified stem and pro-
Gene Therapy genitor cells has demonstrated that HSC constitutively express low levels of many lineage-specific cytokine receptors and transcription factors. 7, 24, 28 Among progenitors, lineage commitment is accompanied by loss of expression of genes associated with unrelated lineages, 7 indicating that hematopoietic maturation may be mediated by sequential restriction of gene expression. Promiscuous gene expression by HSC may provide a framework for stochastic fluctuations in expression of signaling or transcriptional complexes, which ultimately are amplified or repressed to cement lineage choice. 26 Specific molecular mediators that influence HSC selfrenewal versus differentiation decisions have only recently been identified. Increased HSC self-renewal appears to be associated with HSC-intrinsic overexpression of HoxB4, 29, 30 and induction of the Wnt (Reya et al, submitted), Notch, 31, 32 and Sonic hedgehog (Shh) 33 signaling pathways. Extrinsic signals that promote HSC self-renewal have been more difficult to identify, as shown by the notorious lack of effective means of expanding HSC in vitro, while maintaining their selfrenewing properties. Currently published literature [34] [35] [36] [37] [38] points to several cytokines, including SLF, Flt3L, thrombopoietin, IL-3, and IL-6, as working individually or synergistically to permit one to two self-renewing divisions in liquid culture. However, long-term maintenance of HSC function clearly requires more complex systems and may rely on as yet uncharacterized factors provided by stromal support cells (see below). A central issue in HSC fate choices is the consideration of symmetry within stem cell divisions. Are the individual mitoses of HSC obligately symmetric (always producing two daughter cells with identical fates), obligately asymmetric (always producing two daughters with distinct fates), or variably symmetric and asymmetric?
Because in the steady state the total number of BM HSC remains constant, 4 half of all HSC divisions, at the population level, must be self-renewing. However, HSC must also have the capacity to expand their numbers, by increasing the frequency of self-renewal, in response to hematopoietic stress. Thus, HSC divisions cannot be obligately asymmetric, as this would prohibit HSC expansion. Experiments in vitro have provided evidence for both symmetric and asymmetric divisions of cultured HSC, 34, 39 suggesting that the outcomes of HSC mitoses are variable, but the relevance of these findings to HSC divisions in vivo remains to be determined.
Programmed cell death as a determinant of HSC fate
The hematopoietic compartment must produce large numbers of cells daily (~2.4 x 10 8 in the mouse 40 ), and must further scale up this effort following injury or hematopoietic stress. Programmed cell death (apoptosis) of HSC has recently been shown to play an important role in regulating HSC number. Transgenic mice with enforced overexpression of the proto-oncogene Bcl-2 exhibit increased steady-state HSC frequency and increased competitive repopulation potential. 41 When transplanted into irradiated wild-type recipients, Bcl-2 transgenic HSC give increasing hematopoietic readout over time, and in vitro culture of Bcl-2 transgenic HSC with SF alone is sufficient to prevent HSC death. 27 These data demonstrate that regular turnover of BM HSC through programmed cell death is an important regulator of HSC cell fate and hematopoietic homeostasis. The inability of Bcl-2 transgenic HSC to be removed from BM niches by apoptosis may underlie the competitive advantage of these HSC in wild-type transplant recipients.
Adhesion and migration as regulators of HSC fate
In the BM, hematopoietic cell development is thought to occur in various specialized microenvironments, called 'niches'. At present, support for the niche hypothesis remains indirect, and these specialized areas of BM have never been described at the ultrastructural level. Evidence for the existence of HSC-supporting niches derives from several lines of investigation, including the lack of in vitro conditions that can fully support HSC selfrenewal, the infrequency of isolation of hematopoiesis supporting stromal cell lines, 42, 43 and the low level of BM engraftment that can be achieved following intravenous injection of HSC, unless those HSC are given in extraordinarily high numbers or unless the BM is ablated by irradiation or cytotoxic drugs. 44, 45 The hypothetical function of the HSC niche is to provide HSC survival and self-renewal factors, either through direct contact with HSC or through secreted factors. HSC niches are likely formed from a subset of bone marrow stromal cells, which may play a further role in 'translating' external signals to influence HSC developmental decisions. 46 BM stromal cells can play either supportive or inhibitory roles in the maintenance of primitive hematopoietic progenitors. Co-culture of human CD34 +
CD38
Ϫ/lo human progenitor cells with marrow-derived stromal cells appears to promote maintenance of the primitive state, [47] [48] [49] [50] and a unique cloned marrow stromal line (ATF024), derived from murine FL, can maintain murine HSC activity in culture for weeks. 42, 43 On the other hand, while freshly purified marrow myofibroblasts facilitate hematopoietic cell proliferation in vitro, marrow endothelial cells may inhibit hematopoiesis. 51 Whether direct contact of HSC with stromal cells is required for their effects on HSC is somewhat controversial. ATF024 cells fail to support long-term maintenance of primitive human progenitor cells in non-contact cultures, 42 but can maintain SCID-repopulating activity of umbilical cord blood CD34 + cells in transwell assays. 52 Some stromal cell cultures support hematopoiesis in noncontact conditions, but inhibit it in direct co-cultures. 53 The differences in outcome of these in vitro cultures may relate to differences in the source or type of HSC and/or stromal elements studied, or may depend on other differences, such as the presence or absence of cytokines, serum, or other factors, in these culture systems.
The emergence during development of distinct blood cell lineages, dependent on particular stromal microenvironments, supports the importance of stromal cell interactions to HSC fate choices in vivo. For example, the first TCR + thymocytes are V␥3 + and V␥4 + . 20 These T cells arise only from FL HSC and absolutely require the fetal thymic environment for their generation. 19 The involvement of stromal cells in HSC function in vivo is further evident from studies of naturally occurring mutations of the Steel (Sl) locus in mice. BM transplantation has demonstrated that defective hematopoiesis in these mice results from a specific deficiency (loss or impairment of SLF expression) within the BM microenvironment. 54, 55 HSC from Sl mutant mice reconstitute the ablated BM of wild-type animals, while wild-type HSC fail to reconstitute hematopoiesis in transplanted Sl mice and BM stromal cells from these mice fail to support hematopoiesis in vitro. [54] [55] [56] [57] [58] Finally, in recent studies, co-transplantation of stromal elements with either adult or fetal BM HSC significantly enhanced engraftment of preimmune fetal sheep, 59 providing further evidence for support of HSC function by marrow stromal cells.
Extensive and complex interactions within the BM microenvironment clearly influence the cell fate decisions of HSC; however, these interactions do not necessarily imply that HSC remain permanently lodged in specific BM niches. On the contrary, recent data suggests significant dynamism among HSC niches, and supports the notion that migration through the bloodstream to distinct BM sites or to other peripheral tissues is an additional developmental alternative for HSC (Figure 2) . The importance of HSC migration is clearly evident during fetal hematopoiesis. HSC arise first in the embryonic yolk sac [60] [61] [62] [63] [64] [65] and aorta/gonad/mesonephros (AGM) region, [66] [67] [68] [69] and are thought to migrate to and seed the fetal liver. 63, 70, 71 FL HSC subsequently engraft the newly developing fetal BM. In the adult, the ability of hematopoietic cells to use the blood as a transit mechanism for migration from one organ to another was demonstrated more than 40 years ago, [72] [73] [74] but the realization that such migration in the bloodstream is a property not only of mature blood cells, but also of hematopoietic stem and progenitor cells, occurred more recently. HSC and progenitor cells are constantly present at low frequency in the blood of normal animals, 75, 76 and these blood-borne HSC can, at least, re-engraft BM to functionally contrib- ute to on-going hematopoiesis. 76, 110 In genetically marked parabiotic mice, which share a common blood circulation, significant cross-engraftment of BM HSC is observed in the absence of BM ablation following as little as 2-3 weeks of parabiosis (A. Wagers, unpublished observation). This data suggests that constitutive, lowlevel HSC mobilization occurs in normal, unconditioned animals. Surprisingly, the normal flux of HSC and progenitor cells in the bloodstream of normal animals appears to be quite high, as predicted by their extremely short residence time in the blood, such that the effective pool of circulating cells may include more than 30 000 stem and progenitor cells. 110 While the full effects of constitutive migration on HSC developmental decisions remain to be determined, the possibility that HSC may find themselves in unique microenvironments in tissues outside of the BM raises the interesting possibility that itinerant HSC or their progeny may contribute to the regeneration of non-hematopoietic, as well as hematopoietic cells (see below). Furthermore, this finding provides a physiological framework for understanding the efficiency of bone marrow transplantation and the existence of induced HSC mobilization, which occurs following myeloablation and/or increases in circulating cytokine/chemokine levels, 77 as these transplanted or mobilized HSC likely exploit similar mechanisms of migration as those employed by constitutively circulating HSC in normal animals.
Plasticity of stem cell fate
Recently much attention has been paid to stem cells in the adult organism, and the possibility that stem cells may transdifferentiate into cell types of unrelated tissues. Stem cells or cells with stem cell-like qualities have been isolated or described in several tissues, including neural (CNS [78] [79] [80] cell transdifferentiation, some caution is warranted in considering these findings. First, it is important to remember that BM contains several stem cell populations, including mesenchymal and hematopoietic stem cells, and that mesenchymal stem cells are defined by their potential to give rise to muscle, cartilage, bone, fat and stroma. 85 Furthermore, because circulating tissuespecific stem cells, including HSC, have been described for several lineages, such blood-borne stem cells represent significant potential sources of contamination in transdifferentiation assays. 75, 76, [105] [106] [107] 110 Finally, some claims of transdifferentiation involve cells grown in culture, using high concentrations of growth factors, which may impart a more primitive potential to the cultured cells. 103, 104 For example, fetal murine primordial germ cells grown in basic fibroblast growth factor (bFGF) and leukemia inhibitory factor (LIF) take on embryonic stem (ES) cell qualities.
108 Thus, to demonstrate true transdifferentiation, it is necessary that the stem cells in question are prospectively isolated and characterized, able to selfrenew and differentiate into all relevant cell types at the clonal level, and that the transdifferentiated cells generated by these stem cells are demonstrated to be fully functional in the target tissue.
Despite the caveats discussed above, good evidence for a greater than expected plasticity of adult stem cells is emerging, and this research has exciting implications for potential clinical application to the repair of damaged or degenerating tissues. Highly purified HSC have been shown able to differentiate into colonies of hepatocytes when introduced into fumarylacetoacetate hydrolase
109 HSC-derived hepatocytes restored liver function in transplanted FAH Ϫ/Ϫ mice, and all hepatic engrafted recipients also showed hematopoietic reconstitution. Whether hepatic regeneration is a normal role of HSC, or whether this function is induced by the mutant background of the recipient mice, remains to be determined, but these findings certainly demand further inquiry into the possibility of HSC mediated therapy for liver degenerative disorders.
Concluding remarks
Hematopoiesis is regulated by the developmental decisions of HSC, which include self-renewal, differentiation, death, and migration. Much has been learned about the molecular and cellular regulators that influence HSC fate decisions, and recent data suggest that these cells may be significantly more dynamic than previously appreciated. Exciting new studies have called into question long-standing beliefs regarding the tissue-restriction of HSC, and of adult tissue-specific stem cells in general, suggesting the possibility that these stem cells may someday be useful targets for therapeutic strategies aimed at tissue regeneration and repair.
